• The Ticker
  • Message Boards
  • Jobs
  • Medtech[y] Shop
  • 
  • 
  • 
  • View
  • ALL
  • Biotech
  • Medical Device
  • Robotic Surgery
  • Medical Device Sales
  • Medtechy Deals
  • Future of Healthcare
  • Healthcare Fraud
  • Hospitals

Join Our Mailing List Today

Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis Robotic Magnetic Navigation System

Posted in Medical Device

March 06, 2020 • 2 min read

ST. LOUIS, March 06, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today it has received U.S. Food and Drug Administration (FDA) 510(k) clea...

Aerin Medical Announces FDA Clearance and U.S. Launch of Innovative Nonsurgical Procedure for Chronic Rhinitis

Posted in Medical Device

March 05, 2020 • 2 min read

AUSTIN, Texas--(BUSINESS WIRE)--Aerin Medical Inc., a company focused on minimally invasive solutions for chronic nasal conditions, today announced U.S. Food and Drug Administration (FDA) clearance and U.S. launch of the company’s second product, the...

Neovasc Reducer Featured in Peer Reviewed EuroIntervention and PCR Online

Posted in Medical Device

March 03, 2020 • 2 min read

VANCOUVER, March 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and minimally invas...

PROCEPT BioRobotics Announces Three-Year Follow-Up Data Confirming Sustained Efficacy, Superior Safety of Aquablation® Therapy for Benign Prostatic Hyperplasia

Posted in Medical Device

February 27, 2020 • 2 min read

REDWOOD CITY, Calif.--(BUSINESS WIRE)--#bph--PROCEPT BioRobotics Corporation, a surgical robotics company developing intelligent solutions to transform the field of urology, has announced that three-year follow-up data from the blinded, randomized WA...

Senseonics Announces the FDA Approval to Continue the PROMISE Sensor Clinical Study in an Extended Cohort to 365 Days to Gather Feasibility Data

Posted in Medical Device

February 26, 2020 • 2 min read

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system ...

What's the Strategy in the U.S. for Neovasc's Reducer?

Posted in Medical Device

February 25, 2020 • 2 min read

Neovasc (Nasdaq: NVCN) is a medical device company primarily known for Reducer, which is a minimally invasive device that helps treat patients with refractory angina. The device has been approved in Europe...

Nemaura Medical Plans Head-to-head Study with Major Glucose Monitoring System

Posted in Medical Device

February 25, 2020 • 2 min read

LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices ...

Auris Medical Highlights Publication of Study Results Demonstrating Betahistine’s Antiepileptogenic and Anticonvulsant Activity in Murine Model

Posted in Medical Device

February 25, 2020 • 2 min read

Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system...

Endologix Announces Debt Restructuring Addressing 2020 Maturities

Posted in Medical Device

February 24, 2020 • 2 min read

IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today that it has entered into an exchange agreement with three holders ...

Senseonics Reports at ATTD Glycemic Outcomes Across Adult Age Ranges with Real-World Eversense CGM Use

Posted in Medical Device

February 24, 2020 • 2 min read

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system fo...

SUBMIT A TIP

Are you aware of fraud occurring at your workplace or previous place of employment?

Speak up, speak out, do the right thing.

REPORT HEALTHCARE FRAUD

TOP BOARD THREADS
  • Amarin EVAPORATE Study Results
    Amarin Message Board board
  • How do I get into Medical Device Sales?
    Medical Sales General Discussion board
  • What are the Best Biotech Stocks?
    Pharma/Biotech General Discussion board
  • FiercePharma's Top Pharma Companies in the World
    Pharma/Biotech Message Board board
  • Baker Brothers Advisors
    Pharma/Biotech General Discussion board
  • Will the FDA Approval Expanded Label for Vascepa?
    Amarin Message Board board
  • Is Amgen Looking to Acquire MannKind
    MannKind Message Board board
  • MedReps.com Jobs
    Medical Sales General Discussion board
  • Zimmer Biomet Layoffs
    Zimmer Biomet Message Board board
  • Medical Device Reps Back in the OR after COVID-19
    Medical Device Sales General Discussion board
  • READ MORE ON THE BOARDS

FEATURED JOBS
  • Medical Affairs Program Specialist
  • VIEW MORE JOBS

  • First Page
  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page
  • Last Page

Developed by medical sales professionals for medical sales professionals.

 •  @medtechy •  medtechy

copyright Medtechy Inc. ⋅ Report A Tip ⋅ Terms of Use ⋅ Privacy Policy ⋅ DMCA Policy ⋅ Removal Policy ⋅ [email protected]